Eikon Therapeutics is a biopharmaceutical company leveraging innovative technology that merges chemistry, engineering, computation, and biology to develop novel therapies for serious diseases. The company's groundbreaking discovery platform stems from Nobel Prize-winning research, which has led to the creation of advanced microscopy techniques. These techniques facilitate real-time, molecular-resolution tracking of protein dynamics within live cells, thus opening new avenues for identifying previously challenging protein targets as potential drug candidates. Eikon operates with a commitment to advancing medical science and improving patient outcomes through rigorous research and collaboration across multidisciplinary teams. The company values integrity, innovation, and excellence, fostering an environment that encourages scientific inquiry and teamwork.